# Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)

> **NCT02156362** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 643 (estimated)

## Conditions studied

- Thyroid Cancer

## Interventions

- **OTHER:** follow up visit

## Key facts

- **NCT ID:** NCT02156362
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 643 (ESTIMATED)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156362, "Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT02156362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*